Agenus Inc
- Last sale
- Nov 6, 2026 · +11.04%
- Market cap
- $323.06M
- 45.25M shares
- Filings
- 1,047
Q3 2026+10.4% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−92.6% FY25 yoy
- $323.06M
- 10.5×
- 2.4×
- —
- -32.15%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $114,196,000 | reported | |
| FY 2024 | 2024-12-31 | $103,463,000 | reported | |
| FY 2023 | 2023-12-31 | $156,314,000 | reported | |
| FY 2022 | 2022-12-31 | $98,024,000 | reported | |
| FY 2021 | 2021-12-31 | $295,665,000 | reported | |
| FY 2020 | 2020-12-31 | $88,170,000 | reported | |
| FY 2019 | 2019-12-31 | $150,048,000 | reported | |
| FY 2018 | 2018-12-31 | $36,784,000 | reported | |
| FY 2017 | 2017-12-31 | $42,877,000 | reported | |
| FY 2016 | 2016-12-31 | $22,573,303 | reported | |
| FY 2015 | 2015-12-31 | $24,817,025 | reported | |
| FY 2014 | 2014-12-31 | $6,977,455 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $606.00K | $606.00K | — | 418.92M sh | +26.0% | — |
| FY2011 | — | $0.00 | $0.00 | — | 22.49M sh | — | — |
| FY2010 | — | $0.00 | $0.00 | — | — | — | — |
| FY2009 | — | $54.94K | $54.94K | — | — | — | — |
Segments
LineFY2025ShareChange
United States$113.16M99%+11.5%
Rest of World$1.04M0.9%−48.3%
Rest of World———
Total$114.20M
Biological products, except diagnostic substances
Agenus Inc is the 28th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
BEAMBeam Therapeutics Inc.$139.7M120.0%57.2%$2.5BGLUEMonte Rosa Therapeutics, Inc.$123.7M63.5%31.2%$793.0MATRAAtara Biotherapeutics, Inc.$120.8M6.3%27.1%$80.4M
AGENAgenus Inc (this company)$114.2M10.4%2.7%$323.1M
IBRXImmunityBio, Inc.$113.3M668.3%310.2%$6.5BIPSCCentury Therapeutics, Inc.$109.2M1,556.8%8.8%$294.2MSTROSutro Biopharma, Inc.$102.5M65.2%186.5%$159.0MFDMT4D Molecular Therapeutics, Inc.$85.2M230,194.6%164.4%$682.1MMGTXMeiraGTx Holdings plc$81.4M144.6%140.3%$858.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Agenus Inc · CIK 1098972 · Engraved from SEC EDGAR